Breaking News
October 20, 2018 - Antidepressant treatment may lead to improvements in sleep quality of patients with depression
October 20, 2018 - Study reports increased risk of death in children with inflammatory bowel disease
October 20, 2018 - Number of Autism Genes Now Tops 100
October 20, 2018 - Total diet replacement programmes are effective for treating obesity
October 20, 2018 - CLARIOstar used for fluorescence measurements on CSIRO’s purpose-built research vessel
October 20, 2018 - People with more copies of AMY1 gene digest starchy carbohydrates faster
October 20, 2018 - Case Comprehensive Cancer Center wins NIH grant to study health disparities
October 20, 2018 - Newly discovered compound shows potential for treating Parkinson’s disease
October 20, 2018 - High rate of non-adherence to hormonal therapy found among premenopausal early breast cancer patients
October 20, 2018 - Immunotherapy medicine found to be effective in treating uveitis
October 20, 2018 - The Pistoia Alliance Calls for Greater Collaboration to Realise Benefits of Innovation and Announces Winners of the 2018 President’s Startup Challenge
October 20, 2018 - Female internists consistently earn less than men
October 20, 2018 - Stanford team looks at dangers of teens’ vaping habits
October 20, 2018 - New approach to understanding cancers will accelerate development of better treatments
October 20, 2018 - LJI and UC San Diego awarded $ 4.5 million as part of NCI’s Cancer Moonshot initiative
October 20, 2018 - School-based HPV vaccination did not increase risky sexual behaviors among adolescent girls
October 20, 2018 - Eye discovery to pave way for more successful corneal transplants
October 20, 2018 - New analysis examines the importance of location in the opioid crisis
October 20, 2018 - Green filters increase reading speed for children with dyslexia
October 19, 2018 - Bariatric Sx Cuts Macrovascular Complications in Obesity, T2DM
October 19, 2018 - Better assessments for early age-related macular degeneration
October 19, 2018 - Visible and valued: Stanford Medicine’s first-ever LGBTQ+ Forum | News Center
October 19, 2018 - Understanding of metal-free enzymes used by bacteria could lead to new effective antibiotics
October 19, 2018 - Beckman Coulter Life Sciences announces new research-focused website
October 19, 2018 - Study finds link between refined soluble fibers, gut microbiota and liver cancer
October 19, 2018 - Social media reduces risk of depression among seniors with pain
October 19, 2018 - Newly developed synthetic DNA molecule may one day be used as ‘vaccine’ for prostate cancer
October 19, 2018 - Preoperative weight loss may not provide health benefits after surgery
October 19, 2018 - U.S. Birth Rates Continue to Drop as Age of New Moms Rises
October 19, 2018 - New technology can keep an eye on babies’ movements in the womb
October 19, 2018 - Juul e-cigarettes pose addiction risk for young users | News Center
October 19, 2018 - Gene sequencing reveals crucial molecular aspects of Trypanosoma brucei
October 19, 2018 - New DNA vaccine strategy protects mice against lethal challenge by multiple H3N2 viruses
October 19, 2018 - Study shows close link between cytokine interleukin-1ß and obesity-promoted colon cancer
October 19, 2018 - Muscle mass plays a critical role in health, shows research
October 19, 2018 - Study finds undiagnosed prediabetes in many infertile men
October 19, 2018 - The Current issue of “The view from here” is concerned with Nanotherapeutic strategies
October 19, 2018 - Delay in replacing the Pap smear with HPV screening is costing lives
October 19, 2018 - Physicians battle pediatric diseases of ear, nose, throat in Zimbabwe | News Center
October 19, 2018 - Researchers investigate why some cancers affect only young women
October 19, 2018 - Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus
October 19, 2018 - Unselfish people tend to have more children and receive higher salaries
October 19, 2018 - New findings reveal potential cellular players in tumor microenvironment
October 19, 2018 - Some countries take more time for reimbursement decisions on new cancer drugs
October 19, 2018 - Human brain cell transplant offers insights into neurological conditions
October 19, 2018 - Parental education associated with increased family health care spending
October 19, 2018 - New statistical method estimates long- and short-term risk of recurrence of breast cancer in US women
October 19, 2018 - Father’s exposure to nicotine may cause cognitive deficits in descendants
October 19, 2018 - Could we prevent Alzheimer’s disease by treating herpes?
October 19, 2018 - Nurse-led care can be more successful in managing gout
October 19, 2018 - Trump administration, pharma exchange verbal volleys on drug-price transparency
October 19, 2018 - Duke researchers find way to detect blood doping in athletes
October 19, 2018 - Many primary care doctors are still prescribing sedative drugs for older adults
October 19, 2018 - Finger length can predict sexuality in women say researchers
October 19, 2018 - Study finds differences in side-effects experienced by male and female OG cancer patients
October 19, 2018 - Dysfunction of single gene leads to miscarriages
October 19, 2018 - Few Seniors Who Self-Harm Referred for Mental Health Care
October 19, 2018 - Don’t sweat the sweet stuff
October 19, 2018 - URMC researchers discover new approach to deliver therapeutics to the brain
October 19, 2018 - Speech Pathology Australia raises awareness about Developmental Language Disorder
October 19, 2018 - Middlemen suppliers can increase drug prices and hospital bills, say Johns Hopkins researchers
October 19, 2018 - Survey finds high prevalence of HTLV-1 infection among teens and adults in Gabon
October 19, 2018 - Bliss funds research to find whether parental touch can help alleviate pain in premature infants
October 19, 2018 - Human neurons employ highly compartmentalized signaling, study shows
October 19, 2018 - Ultromics expands multiple clinical trials for coronary heart disease to the U.S.
October 19, 2018 - $11 million NIH grant for Clemson University helps launch new center for musculoskeletal research
October 19, 2018 - A new approach identified to control Zika virus, dengue fever
October 19, 2018 - Head Blows Without Concussion May Not Damage Brain, Study Claims
October 19, 2018 - US opioid use not declined, despite focus on abuse and awareness of risk
October 19, 2018 - Next-generation RNA sequencing technology sheds new light on human mitochondrial diseases
October 19, 2018 - UT Southwestern biochemist receives 2019 Breakthrough Prize in Life Sciences for innate immunity discovery
October 19, 2018 - The immune system also plays a key role in day-to-day function of healthy organs
October 19, 2018 - New tool may reveal how the brain structure impacts brain activity, human behavior
October 19, 2018 - Trump Administration announces ‘Winning on Reducing Food Waste’ initiative
October 19, 2018 - For-profit nursing home residents more likely to experience health issues caused by substandard care
October 19, 2018 - Incidence of stroke has risen steadily among marijuana users, show studies
October 19, 2018 - Conceptual framework proposed to examine role of exercise in multiple sclerosis
October 19, 2018 - Near infrared spectroscopy technique for accurate evaluation of chondral injuries
October 19, 2018 - Scientists receive $5.1 million grant to develop stem cell-based therapy for blinding retinal conditions
October 19, 2018 - Shorter physician encounters associated with antibiotic prescribing
Genetic checking out is helping set secure dose of not unusual blood thinner

Genetic checking out is helping set secure dose of not unusual blood thinner

image_pdfDownload PDFimage_print

Warfarin is a blood thinner this is recurrently prescribed to sufferers to stop life-threatening blood clots. In spite of its longtime use, warfarin stays tough to dose as a result of an individual’s genetic make-up influences how the drug is processed within the frame. An excessive amount of warfarin may cause inside bleeding; too little warfarin fails to stop blood clots.

Now, a brand new find out about led via Washington College Faculty of Medication in St. Louis presentations that dosing warfarin (Coumadin and others) is more secure—generating fewer opposed occasions equivalent to hemorrhage—when key components of a affected person’s genetic make-up are regarded as.

The analysis, printed Sept. 26 within the Magazine of the American Clinical Affiliation, experiences effects from the medical trial referred to as GIFT (Genetics Informatics Trial of Warfarin to Save you Deep Venous Thrombosis).

“Physicians were prescribing warfarin because the Eisenhower management,” mentioned first writer Brian F. Gage, MD, a professor of medication at Washington College Faculty of Medication in St. Louis. “It is a broadly used anticoagulant, however it reasons extra primary opposed occasions than another oral drug. 1000’s of sufferers finally end up within the emergency division or medical institution on account of warfarin-induced bleeding. However we proceed to prescribe it as a result of it’s extremely efficient, reversible and affordable. So our function is to make warfarin more secure. GIFT confirmed that precision-medicine according to medical elements and 3 genes improves the security of beginning warfarin treatment.”

Sufferers within the trial have been randomly assigned to one among two teams. One team won warfarin dosing according to same old elements equivalent to age, peak and weight; the second one team used to be dosed according to those medical elements plus genetic variants. Collaborating websites within the trial integrated Washington College Faculty of Medication, Clinic for Particular Surgical procedure in New York, Intermountain Healthcare, College of Utah, and Rush College Clinical Middle.

Of the 789 sufferers who have been dosed within the conventional approach, 116 skilled no less than one opposed tournament (14.7 p.c). Of the 808 sufferers whose warfarin dosing used to be guided via genetic checking out, 87 skilled an opposed tournament (10.eight p.c). In comparison with sufferers receiving conventional warfarin dosing, sufferers dosed with the genetic means had a 27 p.c relief in opposed occasions, which used to be statistically other. The opposed occasions have been bleeding, formation of blood clots within the veins and warfarin overdoses. No affected person died all through the trial.

Previous research having a look at whether or not genetic checking out may give a boost to warfarin dosing had produced conflicting effects. Alternatively, those research have been smaller and regarded as fewer genes than GIFT. GIFT enrolled 1,600 sufferers age 65 and older at top possibility of blood clots as a result of they underwent hip- or knee-replacement surgical procedures.

Not like prior research, GIFT took under consideration genetic variants in 3 genes for 11 days of warfarin treatment. Genetic variants have been assessed on a industrial platform known as GenMarkDx. Variants in a single gene have an effect on nutrition Ok recycling. Variants in any other gene have an effect on warfarin sensitivity. Variants within the 3rd gene modify warfarin metabolism within the liver and will purpose an overdose if the dose isn’t adjusted quickly sufficient.

“There are further genetic variants that can lend a hand to lead warfarin dosing, particularly amongst sufferers with African ancestry,” Gage mentioned. At some point, we are hoping to quantify how those variants have an effect on warfarin.”

Gage additionally famous how health-care prices relate to dosing warfarin in a genetically guided approach. “Even if genetic checking out is dearer than medical dosing, the price is falling,” he mentioned. “In our find out about, we estimated that genetic checking out prices not up to $200 in line with particular person, which is not up to one month of a more moderen anticoagulant.”


Discover additional:
Genetically guided warfarin dosing lowers possibility of a few opposed occasions

Additional info:
Gage BF, Bass AR, Lin H, Woller SC, Stevens SM, Al-Hammadi N, Li J, Rodriguez Jr. T, Miller JP, McMillin GA, Pendleton RC, Jaffer AK, King CR, DeVore B, Porche-Sorbet R, Napoli L, Merritt Ok, Thompson AM, Hyun G, Anderson JL, Hollomon W, Barrack RL, Nunley RM, Moskowitz G, Davila-Roman V and Eby CS for the GIFT investigators. Impact of genotype-guided warfarin dosing on medical occasions and anticoagulation regulate amongst sufferers present process hip or knee arthroplasty: the GIFT randomized medical trial. Magazine of the American Clinical Affiliation. Sept. 26, 2017. DOI: 10.1001/jama.2017.11463

Magazine reference:
Magazine of the American Clinical Affiliation

Supplied via:
Washington College Faculty of Medication

Tagged with:

About author

Related Articles